The role of HMG-CoA reductase inhibition in patients with cardiovascular disease
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Macclesfield, Cheshire
Gardiner-Caldwell Communications
1992
|
| Schriftenreihe: | Journal of drug development / Supplement
4,4 |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV006321499 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t| | ||
| 008 | 930222s1992 xx d||| |||| 10||| engod | ||
| 035 | |a (OCoLC)34595463 | ||
| 035 | |a (DE-599)BVBBV006321499 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| 264 | 1 | |a Macclesfield, Cheshire |b Gardiner-Caldwell Communications |c 1992 | |
| 300 | |a 27 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Journal of drug development / Supplement |v 4,4 | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 650 | 0 | 7 | |a Pravastatin |0 (DE-588)4255787-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hydroxymethylglutaryl-CoA-Reductase |0 (DE-588)4161000-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Inhibitor |0 (DE-588)4027007-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Pravastatin |0 (DE-588)4255787-2 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hydroxymethylglutaryl-CoA-Reductase |0 (DE-588)4161000-3 |D s |
| 689 | 1 | 1 | |a Inhibitor |0 (DE-588)4027007-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 810 | 2 | |a Supplement |t Journal of drug development |v 4,4 |w (DE-604)BV008922135 |9 4,4 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-003999550 | |
Datensatz im Suchindex
| _version_ | 1819232727831937027 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV006321499 |
| ctrlnum | (OCoLC)34595463 (DE-599)BVBBV006321499 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01481nam a2200397 cb4500</leader><controlfield tag="001">BV006321499</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">930222s1992 xx d||| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34595463</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006321499</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The role of HMG-CoA reductase inhibition in patients with cardiovascular disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Macclesfield, Cheshire</subfield><subfield code="b">Gardiner-Caldwell Communications</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">27 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Journal of drug development / Supplement</subfield><subfield code="v">4,4</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pravastatin</subfield><subfield code="0">(DE-588)4255787-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hydroxymethylglutaryl-CoA-Reductase</subfield><subfield code="0">(DE-588)4161000-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pravastatin</subfield><subfield code="0">(DE-588)4255787-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hydroxymethylglutaryl-CoA-Reductase</subfield><subfield code="0">(DE-588)4161000-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Journal of drug development</subfield><subfield code="v">4,4</subfield><subfield code="w">(DE-604)BV008922135</subfield><subfield code="9">4,4</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003999550</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV006321499 |
| illustrated | Illustrated |
| indexdate | 2024-12-23T12:05:21Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003999550 |
| oclc_num | 34595463 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 27 S. graph. Darst. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Gardiner-Caldwell Communications |
| record_format | marc |
| series2 | Journal of drug development / Supplement |
| spelling | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease Macclesfield, Cheshire Gardiner-Caldwell Communications 1992 27 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Journal of drug development / Supplement 4,4 Einzelaufnahme eines Zs.-Heftes Pravastatin (DE-588)4255787-2 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd rswk-swf Inhibitor (DE-588)4027007-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Pravastatin (DE-588)4255787-2 s Pharmakologie (DE-588)4045687-0 s DE-604 Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 s Inhibitor (DE-588)4027007-5 s Supplement Journal of drug development 4,4 (DE-604)BV008922135 4,4 |
| spellingShingle | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease Pravastatin (DE-588)4255787-2 gnd Pharmakologie (DE-588)4045687-0 gnd Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd Inhibitor (DE-588)4027007-5 gnd |
| subject_GND | (DE-588)4255787-2 (DE-588)4045687-0 (DE-588)4161000-3 (DE-588)4027007-5 (DE-588)1071861417 |
| title | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_auth | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_exact_search | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_full | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_fullStr | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_full_unstemmed | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_short | The role of HMG-CoA reductase inhibition in patients with cardiovascular disease |
| title_sort | the role of hmg coa reductase inhibition in patients with cardiovascular disease |
| topic | Pravastatin (DE-588)4255787-2 gnd Pharmakologie (DE-588)4045687-0 gnd Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd Inhibitor (DE-588)4027007-5 gnd |
| topic_facet | Pravastatin Pharmakologie Hydroxymethylglutaryl-CoA-Reductase Inhibitor Konferenzschrift |
| volume_link | (DE-604)BV008922135 |